Hybrid Conferencee

International Conference on Immune Pathology of Viral Diseases (ICIPVD - 27)

12th - 13th February 2027 | Lisbon, Portugal
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 12–13 February 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 4 SDGs SDGs 3, 4, 9 and 11
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

12 FEB 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Advancements in Viral Pathology
    34
    Track Overview

    This track focuses on the latest research and discoveries in the pathology of viral infections. It aims to explore the mechanisms by which viruses induce disease and the subsequent immune responses.

    Track 02
    Immunological Responses to Viral Infections
    34
    Track Overview

    This session will delve into the intricate interactions between viral pathogens and the human immune system. Participants will discuss how these interactions influence disease outcomes and therapeutic strategies.

    Track 03
    Emerging Viral Threats and Public Health
    311
    Track Overview

    This track addresses the challenges posed by emerging viral diseases and their implications for public health. It will highlight strategies for surveillance, prevention, and response to outbreaks.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Viral Hepatitis: Pathogenesis and Treatment
    34
    Track Overview

    Focusing on viral hepatitis, this session will cover the pathogenesis of hepatitis viruses and current treatment modalities. Discussions will also include the role of immunotherapy in managing chronic infections.

    Track 05
    Vaccination Strategies Against Viral Diseases
    34
    Track Overview

    This track will explore innovative vaccination strategies and their effectiveness against various viral diseases. It aims to discuss the role of vaccines in controlling outbreaks and enhancing immunity.

    Track 06
    Viral Ecology and Transmission Dynamics
    311
    Track Overview

    This session will examine the ecological factors influencing viral transmission and persistence in populations. It will also address the implications of these dynamics for disease control and prevention.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

13 FEB 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Novel Antiviral Agents: Development and Challenges
    39
    Track Overview

    This track will focus on the discovery and development of new antiviral agents targeting various viral pathogens. Discussions will include the challenges faced in clinical trials and regulatory approval.

    Track 08
    Infectious Agents and Immune Evasion Mechanisms
    34
    Track Overview

    This session will investigate how various infectious agents evade the host immune response. It will highlight the implications of these mechanisms for vaccine development and therapeutic interventions.

    Track 09
    Pediatric Viral Infections: Challenges and Solutions
    34
    Track Overview

    This track will address the unique challenges posed by viral infections in pediatric populations. It will focus on prevention, diagnosis, and management strategies tailored for children.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Hemorrhagic Fevers: Pathophysiology and Management
    34
    Track Overview

    This session will explore the pathophysiological mechanisms underlying hemorrhagic fevers caused by viral infections. It will also discuss current management strategies and research on potential treatments.

    Track 11
    Global Health Perspectives on Viral Diseases
    311
    Track Overview

    This track will provide a global perspective on the impact of viral diseases on health systems. It will discuss international collaboration and policy approaches to address viral outbreaks and improve health outcomes.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 11 Sustainable Cities and Communities

Be Part of ICIPVD-27

Submit your research or complete your conference registration.